收藏本站 万方检测 维普检测 中文降重 英文语法检测 Turnitin UK版 Turnitin 国际版
登录 注册

文献互助-谷粉互助｜10秒响应文献互助平台

[Elsevier/Sciencedirect] Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial.

 关闭 求助已关闭
anydym 发表于 2026-9-6 16:40:00 | 显示全部楼层 |阅读模式
悬赏20积分


DOI号:10.1016/S2468-1253(24)00200-0

文献链接:Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial - PubMed

文献作者:Matthew C Choy 1, Christopher F D Li Wai Suen 1, Danny Con 1, Kristy Boyd 2, Raquel Pena 2, Kathryn Burrell 2, Ourania Rosella 2, David Proud 3, Richard Brouwer 3, Alexandra Gorelik 4, Danny Liew 5, William R Connell 6, Emily K Wright 6, Kirstin M Taylor 7, Aviv Pudipeddi 8, Michelle Sawers 9, Britt Christensen 10, Watson Ng 11, Jakob Begun 12, Graham Radford-Smith 13, Mayur Garg 14, Neal Martin 15, Daniel R van Langenberg 16, Nik S Ding 6, Lauren Beswick 9, Rupert W Leong 8, Miles P Sparrow 7, Peter De Cruz 17

备注信息:Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial - The Lancet Gastroenterology & Hepatology
回复

使用道具 捐赠获取积分 应助有误反馈

全部回复0 显示全部楼层

发表回复

高级模式
B Color Image Link Quote Code Smilies
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

anydym Lv.4
VIP会员

  • 发布

  • 回复

  • 积分

    5440

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）


返回列表